title: [Intracerebral haemorrhage].
abstract: Primary intracerebral haemorrhage (ICH) is a life threatening condition with a 60-70% risk for dependency or death at one year follow-up. Currently, acute neurointensive care and rehabilitation in a stroke unit is the only treatment that can improve survival and functional outcome. Evacuation of hematoma within 72 hours of symptom onset has not proved effective in general, but can be considered for selected patients. The question of whether the prevention of hematoma growth can improve outcome through medical haemostatic treatment needs to be proven in a randomised controlled trial.
authors.affiliation: Arhus Universitetshospital, Arhus Sygehus, Neurologisk Afdeling, Arhus C. gande@as.aaa.dk
authors.forename: Grethe
authors.initials: G
authors.lastname: Andersen
authors.forename: Per
authors.initials: P
authors.lastname: Meden
authors.forename: Karsten
authors.initials: K
authors.lastname: Overgaard
authors.forename: Jannick
authors.initials: J
authors.lastname: Brennum
mesh_terms: D002543:Cerebral Hemorrhage / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D006406:Hematoma / Q000188:drug therapy / Q000209:etiology / Q000601:surgery; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D008279:Magnetic Resonance Imaging; D011379:Prognosis; D012008:Recurrence; D020521:Stroke / Q000150:complications / Q000628:therapy; D000071939:Stroke Rehabilitation; D014057:Tomography, X-Ray Computed
chemical_list: D006490:Hemostatics